Vol. 8, Issue 4 (2019)
The clinical study of primary gout and comparative evaluation of Habb-E-Suranjan with allopurinol in its management
Author(s): Hilal Akhtar and Misbahuddin Siddiqi
Abstract: Gout (Niqras) involves many aspects of a person’s life and increasing prevalence placing a huge burden on Nations health. The study aim was to assess the efficacy and safety of Unani pharmacopoeial formulation Habb-e-Suranjan on primary gouty patients. This was an 18 months, randomized open with Standard control study, carried out on 60 patients (30 Test group+30 Control group) and improvements in subjective parameters were assessed weekly and in objective parameter at the baseline, 15 days and 30 days. The subjective parameters were graded arbitrarily from 0- 3 according to severity in both group. There was a significant improvement in subjective and objective parameters in both groups and no adverse effects were observed during and after trial. Thus, it can be concluded that Habb-e-suranjan and Allopurinol both were significantly effective in resolving the symptoms and signs of gouty arthritis and both have significant effect on reducing serum uric acid level.
How to cite this article:
Hilal Akhtar, Misbahuddin Siddiqi. The clinical study of primary gout and comparative evaluation of Habb-E-Suranjan with allopurinol in its management. J Pharmacogn Phytochem 2019;8(4):84-90.